This research report provides a comprehensive analysis of the Cancer Genome Sequencing market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Cancer Genome Sequencing market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Cancer Genome Sequencing, challenges faced by the industry, and potential opportunities for market players.
The global Cancer Genome Sequencing market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Cancer Genome Sequencing market presents opportunities for various stakeholders, including Treatment, Research. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Cancer Genome Sequencing market. Additionally, the growing consumer demand present avenues for market expansion.
The global Cancer Genome Sequencing market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period.
It is a laboratory technique that characterizes DNA or RNA sequences of primary tumor tissue, the tumor micro environment (such as stromal / fibroblast cells), adjacent or distal normal tissue, or metastatic tumor sites. This technique generates information related to identification of nucleotide bases (DNA or RNA), mutation status, copy number and sequence variants, as well as structural variations including fusion genes and chromosomal translocations.
Key Features:
The research report on the Cancer Genome Sequencing market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Cancer Genome Sequencing market.
Market Overview: The report provides a comprehensive overview of the Cancer Genome Sequencing market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Second Generation, Third Generation), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Cancer Genome Sequencing market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Cancer Genome Sequencing market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Cancer Genome Sequencing market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Cancer Genome Sequencing market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Cancer Genome Sequencing market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Cancer Genome Sequencing market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Cancer Genome Sequencing, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Cancer Genome Sequencing market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Cancer Genome Sequencing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Second Generation
Third Generation
Market segment by Application
Treatment
Research
Global Cancer Genome Sequencing Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Agilent Technologies
GE Healthcare Life Sciences
Johnson & Johnson
LI-COR Biosciences
Abbott Laboratories
Beckman Coulter
Bayer
Hamilton Thorne Biosciences
Integrated DNA Technologies
Microchip Biotechnologies
Myriad Genetics
Commonwealth Biotechnologies
ZS Genetics
Pacific Biosciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cancer Genome Sequencing, market overview.
Chapter 2: Global Cancer Genome Sequencing market size in revenue.
Chapter 3: Detailed analysis of Cancer Genome Sequencing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cancer Genome Sequencing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Genome Sequencing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Genome Sequencing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Genome Sequencing Overall Market Size
2.1 Global Cancer Genome Sequencing Market Size: 2023 VS 2030
2.2 Global Cancer Genome Sequencing Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Genome Sequencing Players in Global Market
3.2 Top Global Cancer Genome Sequencing Companies Ranked by Revenue
3.3 Global Cancer Genome Sequencing Revenue by Companies
3.4 Top 3 and Top 5 Cancer Genome Sequencing Companies in Global Market, by Revenue in 2023
3.5 Global Companies Cancer Genome Sequencing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Genome Sequencing Players in Global Market
3.6.1 List of Global Tier 1 Cancer Genome Sequencing Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Genome Sequencing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer Genome Sequencing Market Size Markets, 2023 & 2030
4.1.2 Second Generation
4.1.3 Third Generation
4.2 By Type - Global Cancer Genome Sequencing Revenue & Forecasts
4.2.1 By Type - Global Cancer Genome Sequencing Revenue, 2019-2024
4.2.2 By Type - Global Cancer Genome Sequencing Revenue, 2025-2030
4.2.3 By Type - Global Cancer Genome Sequencing Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Genome Sequencing Market Size, 2023 & 2030
5.1.2 Treatment
5.1.3 Research
5.2 By Application - Global Cancer Genome Sequencing Revenue & Forecasts
5.2.1 By Application - Global Cancer Genome Sequencing Revenue, 2019-2024
5.2.2 By Application - Global Cancer Genome Sequencing Revenue, 2025-2030
5.2.3 By Application - Global Cancer Genome Sequencing Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Cancer Genome Sequencing Market Size, 2023 & 2030
6.2 By Region - Global Cancer Genome Sequencing Revenue & Forecasts
6.2.1 By Region - Global Cancer Genome Sequencing Revenue, 2019-2024
6.2.2 By Region - Global Cancer Genome Sequencing Revenue, 2025-2030
6.2.3 By Region - Global Cancer Genome Sequencing Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Cancer Genome Sequencing Revenue, 2019-2030
6.3.2 US Cancer Genome Sequencing Market Size, 2019-2030
6.3.3 Canada Cancer Genome Sequencing Market Size, 2019-2030
6.3.4 Mexico Cancer Genome Sequencing Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Cancer Genome Sequencing Revenue, 2019-2030
6.4.2 Germany Cancer Genome Sequencing Market Size, 2019-2030
6.4.3 France Cancer Genome Sequencing Market Size, 2019-2030
6.4.4 U.K. Cancer Genome Sequencing Market Size, 2019-2030
6.4.5 Italy Cancer Genome Sequencing Market Size, 2019-2030
6.4.6 Russia Cancer Genome Sequencing Market Size, 2019-2030
6.4.7 Nordic Countries Cancer Genome Sequencing Market Size, 2019-2030
6.4.8 Benelux Cancer Genome Sequencing Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Cancer Genome Sequencing Revenue, 2019-2030
6.5.2 China Cancer Genome Sequencing Market Size, 2019-2030
6.5.3 Japan Cancer Genome Sequencing Market Size, 2019-2030
6.5.4 South Korea Cancer Genome Sequencing Market Size, 2019-2030
6.5.5 Southeast Asia Cancer Genome Sequencing Market Size, 2019-2030
6.5.6 India Cancer Genome Sequencing Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Cancer Genome Sequencing Revenue, 2019-2030
6.6.2 Brazil Cancer Genome Sequencing Market Size, 2019-2030
6.6.3 Argentina Cancer Genome Sequencing Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Genome Sequencing Revenue, 2019-2030
6.7.2 Turkey Cancer Genome Sequencing Market Size, 2019-2030
6.7.3 Israel Cancer Genome Sequencing Market Size, 2019-2030
6.7.4 Saudi Arabia Cancer Genome Sequencing Market Size, 2019-2030
6.7.5 UAE Cancer Genome Sequencing Market Size, 2019-2030
7 Cancer Genome Sequencing Companies Profiles
7.1 Agilent Technologies
7.1.1 Agilent Technologies Company Summary
7.1.2 Agilent Technologies Business Overview
7.1.3 Agilent Technologies Cancer Genome Sequencing Major Product Offerings
7.1.4 Agilent Technologies Cancer Genome Sequencing Revenue in Global Market (2019-2024)
7.1.5 Agilent Technologies Key News & Latest Developments
7.2 GE Healthcare Life Sciences
7.2.1 GE Healthcare Life Sciences Company Summary
7.2.2 GE Healthcare Life Sciences Business Overview
7.2.3 GE Healthcare Life Sciences Cancer Genome Sequencing Major Product Offerings
7.2.4 GE Healthcare Life Sciences Cancer Genome Sequencing Revenue in Global Market (2019-2024)
7.2.5 GE Healthcare Life Sciences Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Cancer Genome Sequencing Major Product Offerings
7.3.4 Johnson & Johnson Cancer Genome Sequencing Revenue in Global Market (2019-2024)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 LI-COR Biosciences
7.4.1 LI-COR Biosciences Company Summary
7.4.2 LI-COR Biosciences Business Overview
7.4.3 LI-COR Biosciences Cancer Genome Sequencing Major Product Offerings
7.4.4 LI-COR Biosciences Cancer Genome Sequencing Revenue in Global Market (2019-2024)
7.4.5 LI-COR Biosciences Key News & Latest Developments
7.5 Abbott Laboratories
7.5.1 Abbott Laboratories Company Summary
7.5.2 Abbott Laboratories Business Overview
7.5.3 Abbott Laboratories Cancer Genome Sequencing Major Product Offerings
7.5.4 Abbott Laboratories Cancer Genome Sequencing Revenue in Global Market (2019-2024)
7.5.5 Abbott Laboratories Key News & Latest Developments
7.6 Beckman Coulter
7.6.1 Beckman Coulter Company Summary
7.6.2 Beckman Coulter Business Overview
7.6.3 Beckman Coulter Cancer Genome Sequencing Major Product Offerings
7.6.4 Beckman Coulter Cancer Genome Sequencing Revenue in Global Market (2019-2024)
7.6.5 Beckman Coulter Key News & Latest Developments
7.7 Bayer
7.7.1 Bayer Company Summary
7.7.2 Bayer Business Overview
7.7.3 Bayer Cancer Genome Sequencing Major Product Offerings
7.7.4 Bayer Cancer Genome Sequencing Revenue in Global Market (2019-2024)
7.7.5 Bayer Key News & Latest Developments
7.8 Hamilton Thorne Biosciences
7.8.1 Hamilton Thorne Biosciences Company Summary
7.8.2 Hamilton Thorne Biosciences Business Overview
7.8.3 Hamilton Thorne Biosciences Cancer Genome Sequencing Major Product Offerings
7.8.4 Hamilton Thorne Biosciences Cancer Genome Sequencing Revenue in Global Market (2019-2024)
7.8.5 Hamilton Thorne Biosciences Key News & Latest Developments
7.9 Integrated DNA Technologies
7.9.1 Integrated DNA Technologies Company Summary
7.9.2 Integrated DNA Technologies Business Overview
7.9.3 Integrated DNA Technologies Cancer Genome Sequencing Major Product Offerings
7.9.4 Integrated DNA Technologies Cancer Genome Sequencing Revenue in Global Market (2019-2024)
7.9.5 Integrated DNA Technologies Key News & Latest Developments
7.10 Microchip Biotechnologies
7.10.1 Microchip Biotechnologies Company Summary
7.10.2 Microchip Biotechnologies Business Overview
7.10.3 Microchip Biotechnologies Cancer Genome Sequencing Major Product Offerings
7.10.4 Microchip Biotechnologies Cancer Genome Sequencing Revenue in Global Market (2019-2024)
7.10.5 Microchip Biotechnologies Key News & Latest Developments
7.11 Myriad Genetics
7.11.1 Myriad Genetics Company Summary
7.11.2 Myriad Genetics Business Overview
7.11.3 Myriad Genetics Cancer Genome Sequencing Major Product Offerings
7.11.4 Myriad Genetics Cancer Genome Sequencing Revenue in Global Market (2019-2024)
7.11.5 Myriad Genetics Key News & Latest Developments
7.12 Commonwealth Biotechnologies
7.12.1 Commonwealth Biotechnologies Company Summary
7.12.2 Commonwealth Biotechnologies Business Overview
7.12.3 Commonwealth Biotechnologies Cancer Genome Sequencing Major Product Offerings
7.12.4 Commonwealth Biotechnologies Cancer Genome Sequencing Revenue in Global Market (2019-2024)
7.12.5 Commonwealth Biotechnologies Key News & Latest Developments
7.13 ZS Genetics
7.13.1 ZS Genetics Company Summary
7.13.2 ZS Genetics Business Overview
7.13.3 ZS Genetics Cancer Genome Sequencing Major Product Offerings
7.13.4 ZS Genetics Cancer Genome Sequencing Revenue in Global Market (2019-2024)
7.13.5 ZS Genetics Key News & Latest Developments
7.14 Pacific Biosciences
7.14.1 Pacific Biosciences Company Summary
7.14.2 Pacific Biosciences Business Overview
7.14.3 Pacific Biosciences Cancer Genome Sequencing Major Product Offerings
7.14.4 Pacific Biosciences Cancer Genome Sequencing Revenue in Global Market (2019-2024)
7.14.5 Pacific Biosciences Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Genome Sequencing Market Opportunities & Trends in Global Market
Table 2. Cancer Genome Sequencing Market Drivers in Global Market
Table 3. Cancer Genome Sequencing Market Restraints in Global Market
Table 4. Key Players of Cancer Genome Sequencing in Global Market
Table 5. Top Cancer Genome Sequencing Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Cancer Genome Sequencing Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Cancer Genome Sequencing Revenue Share by Companies, 2019-2024
Table 8. Global Companies Cancer Genome Sequencing Product Type
Table 9. List of Global Tier 1 Cancer Genome Sequencing Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Genome Sequencing Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Cancer Genome Sequencing Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Cancer Genome Sequencing Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Cancer Genome Sequencing Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Cancer Genome Sequencing Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Cancer Genome Sequencing Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Cancer Genome Sequencing Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Cancer Genome Sequencing Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Cancer Genome Sequencing Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Cancer Genome Sequencing Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Cancer Genome Sequencing Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Cancer Genome Sequencing Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Cancer Genome Sequencing Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Cancer Genome Sequencing Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Cancer Genome Sequencing Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Cancer Genome Sequencing Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Cancer Genome Sequencing Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Cancer Genome Sequencing Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Cancer Genome Sequencing Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Cancer Genome Sequencing Revenue, (US$, Mn), 2025-2030
Table 30. Agilent Technologies Company Summary
Table 31. Agilent Technologies Cancer Genome Sequencing Product Offerings
Table 32. Agilent Technologies Cancer Genome Sequencing Revenue (US$, Mn) & (2019-2024)
Table 33. Agilent Technologies Key News & Latest Developments
Table 34. GE Healthcare Life Sciences Company Summary
Table 35. GE Healthcare Life Sciences Cancer Genome Sequencing Product Offerings
Table 36. GE Healthcare Life Sciences Cancer Genome Sequencing Revenue (US$, Mn) & (2019-2024)
Table 37. GE Healthcare Life Sciences Key News & Latest Developments
Table 38. Johnson & Johnson Company Summary
Table 39. Johnson & Johnson Cancer Genome Sequencing Product Offerings
Table 40. Johnson & Johnson Cancer Genome Sequencing Revenue (US$, Mn) & (2019-2024)
Table 41. Johnson & Johnson Key News & Latest Developments
Table 42. LI-COR Biosciences Company Summary
Table 43. LI-COR Biosciences Cancer Genome Sequencing Product Offerings
Table 44. LI-COR Biosciences Cancer Genome Sequencing Revenue (US$, Mn) & (2019-2024)
Table 45. LI-COR Biosciences Key News & Latest Developments
Table 46. Abbott Laboratories Company Summary
Table 47. Abbott Laboratories Cancer Genome Sequencing Product Offerings
Table 48. Abbott Laboratories Cancer Genome Sequencing Revenue (US$, Mn) & (2019-2024)
Table 49. Abbott Laboratories Key News & Latest Developments
Table 50. Beckman Coulter Company Summary
Table 51. Beckman Coulter Cancer Genome Sequencing Product Offerings
Table 52. Beckman Coulter Cancer Genome Sequencing Revenue (US$, Mn) & (2019-2024)
Table 53. Beckman Coulter Key News & Latest Developments
Table 54. Bayer Company Summary
Table 55. Bayer Cancer Genome Sequencing Product Offerings
Table 56. Bayer Cancer Genome Sequencing Revenue (US$, Mn) & (2019-2024)
Table 57. Bayer Key News & Latest Developments
Table 58. Hamilton Thorne Biosciences Company Summary
Table 59. Hamilton Thorne Biosciences Cancer Genome Sequencing Product Offerings
Table 60. Hamilton Thorne Biosciences Cancer Genome Sequencing Revenue (US$, Mn) & (2019-2024)
Table 61. Hamilton Thorne Biosciences Key News & Latest Developments
Table 62. Integrated DNA Technologies Company Summary
Table 63. Integrated DNA Technologies Cancer Genome Sequencing Product Offerings
Table 64. Integrated DNA Technologies Cancer Genome Sequencing Revenue (US$, Mn) & (2019-2024)
Table 65. Integrated DNA Technologies Key News & Latest Developments
Table 66. Microchip Biotechnologies Company Summary
Table 67. Microchip Biotechnologies Cancer Genome Sequencing Product Offerings
Table 68. Microchip Biotechnologies Cancer Genome Sequencing Revenue (US$, Mn) & (2019-2024)
Table 69. Microchip Biotechnologies Key News & Latest Developments
Table 70. Myriad Genetics Company Summary
Table 71. Myriad Genetics Cancer Genome Sequencing Product Offerings
Table 72. Myriad Genetics Cancer Genome Sequencing Revenue (US$, Mn) & (2019-2024)
Table 73. Myriad Genetics Key News & Latest Developments
Table 74. Commonwealth Biotechnologies Company Summary
Table 75. Commonwealth Biotechnologies Cancer Genome Sequencing Product Offerings
Table 76. Commonwealth Biotechnologies Cancer Genome Sequencing Revenue (US$, Mn) & (2019-2024)
Table 77. Commonwealth Biotechnologies Key News & Latest Developments
Table 78. ZS Genetics Company Summary
Table 79. ZS Genetics Cancer Genome Sequencing Product Offerings
Table 80. ZS Genetics Cancer Genome Sequencing Revenue (US$, Mn) & (2019-2024)
Table 81. ZS Genetics Key News & Latest Developments
Table 82. Pacific Biosciences Company Summary
Table 83. Pacific Biosciences Cancer Genome Sequencing Product Offerings
Table 84. Pacific Biosciences Cancer Genome Sequencing Revenue (US$, Mn) & (2019-2024)
Table 85. Pacific Biosciences Key News & Latest Developments
List of Figures
Figure 1. Cancer Genome Sequencing Segment by Type in 2023
Figure 2. Cancer Genome Sequencing Segment by Application in 2023
Figure 3. Global Cancer Genome Sequencing Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Cancer Genome Sequencing Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Cancer Genome Sequencing Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Genome Sequencing Revenue in 2023
Figure 8. By Type - Global Cancer Genome Sequencing Revenue Market Share, 2019-2030
Figure 9. By Application - Global Cancer Genome Sequencing Revenue Market Share, 2019-2030
Figure 10. By Type - Global Cancer Genome Sequencing Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Cancer Genome Sequencing Revenue Market Share, 2019-2030
Figure 12. By Application - Global Cancer Genome Sequencing Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Cancer Genome Sequencing Revenue Market Share, 2019-2030
Figure 14. By Region - Global Cancer Genome Sequencing Revenue Market Share, 2019-2030
Figure 15. By Country - North America Cancer Genome Sequencing Revenue Market Share, 2019-2030
Figure 16. US Cancer Genome Sequencing Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Cancer Genome Sequencing Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Cancer Genome Sequencing Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Cancer Genome Sequencing Revenue Market Share, 2019-2030
Figure 20. Germany Cancer Genome Sequencing Revenue, (US$, Mn), 2019-2030
Figure 21. France Cancer Genome Sequencing Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Cancer Genome Sequencing Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Cancer Genome Sequencing Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Cancer Genome Sequencing Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Cancer Genome Sequencing Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Cancer Genome Sequencing Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Cancer Genome Sequencing Revenue Market Share, 2019-2030
Figure 28. China Cancer Genome Sequencing Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Cancer Genome Sequencing Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Cancer Genome Sequencing Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Cancer Genome Sequencing Revenue, (US$, Mn), 2019-2030
Figure 32. India Cancer Genome Sequencing Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Cancer Genome Sequencing Revenue Market Share, 2019-2030
Figure 34. Brazil Cancer Genome Sequencing Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Cancer Genome Sequencing Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Cancer Genome Sequencing Revenue Market Share, 2019-2030
Figure 37. Turkey Cancer Genome Sequencing Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Cancer Genome Sequencing Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Cancer Genome Sequencing Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Cancer Genome Sequencing Revenue, (US$, Mn), 2019-2030
Figure 41. Agilent Technologies Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. GE Healthcare Life Sciences Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Johnson & Johnson Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. LI-COR Biosciences Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Abbott Laboratories Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Beckman Coulter Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Bayer Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Hamilton Thorne Biosciences Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Integrated DNA Technologies Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Microchip Biotechnologies Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Myriad Genetics Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Commonwealth Biotechnologies Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. ZS Genetics Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. Pacific Biosciences Cancer Genome Sequencing Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
